Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.22 | $0 | -$7M |
| 2025 Q4 | -0.43 | $0 | -$5M |
| 2025 Q3 | -1.12 | $0 | -$7M |
| 2025 Q2 | -0.43 | $0 | -$5M |
| 2025 Q1 | -0.42 | $0 | -$4M |
| 2024 Q4 | -0.24 | $0 | -$3M |
| 2024 Q3 |
| -0.31 |
| $0 |
| -$3M |
| 2024 Q2 | -0.51 | $0 | -$3M |